Can estrogen protect hearts in early menopause? new study aims to find out

NCT ID NCT06866119

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study will follow 45 women with primary ovarian insufficiency (POI)—a condition that causes early menopause—who are starting estrogen replacement therapy. Researchers will measure heart health markers before and after 6 months of treatment and compare them to healthy women without POI. The goal is to see if estrogen therapy improves blood vessel function and other metabolic signs related to heart disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
estrogen replacement therapy (transdermal 17beta-estradiol and progesterone)
What this could lead to
If successful, this could provide stronger evidence that estrogen therapy helps protect the heart in women with early menopause.
What could go wrong
This is a small observational study (45 participants) that does not test a new treatment—it only measures existing therapy effects. Results may not apply to all women with POI.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOTHELIAL FUNCTION (FMD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.